Drug Profile
Research programme: opioid receptor antagonists - GlaxoSmithKline
Alternative Names: GSK 982Latest Information Update: 19 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Benzimidazoles; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 21 Aug 2008 Preclinical trials in Obesity in USA (PO)